Discover the detailed record of transactions filed by 尹晨阳, Director. Officer active across 1 company, notably 福鞍股份. Aggregated, 46 reports have been recorded. History available since 2 January 2025. The latest transaction was disclosed on 25 April 2025 (Purchase). Regulator: SSE / SZSE (CSRC). All data is openly available.
Declarations 46 total
● 董事 · Executives · 27 Nov 2025 · 福鞍股份 80,000 shares A股 SSE:173000009835496400 ● 董事 · Executives · 24 Nov 2025 · 福鞍股份 30,000 shares A股 SSE:173000009827576740 ● 董事 · Executives · 17 Nov 2025 · 福鞍股份 30,000 shares A股 SSE:173000009783837660 ● 高级管理人员 · Executives · 17 Nov 2025 · 福鞍股份 8,000 shares A股 SSE:173000009783837730 ● 董事 · Executives · 13 Nov 2025 · 福鞍股份 10,000 shares A股 SSE:173000009775577400 ● 董事 · Executives · 11 Nov 2025 · 福鞍股份 69,900 shares A股 SSE:173000009738442370 ● 董事 · Executives · 10 Nov 2025 · 福鞍股份 20,000 shares A股 SSE:173000009726371520 ● 董事 · Executives · 6 Nov 2025 · 福鞍股份 6,000 shares A股 SSE:173000009717809800 ● 高级管理人员 · Executives · 6 Nov 2025 · 福鞍股份 20,000 shares A股 SSE:173000009717809440 ● 高级管理人员 · Executives · 6 Nov 2025 · 福鞍股份 10,000 shares A股 SSE:173000009717809470 ● 董事 · Executives · 5 Nov 2025 · 福鞍股份 50,000 shares A股 SSE:173000009712471970 ● 高管 · Executives · 25 Apr 2025 · 派林生物 5,000 shares A股 SZSE:173000008868500400 Ideal exit: 20 Jan 2026 (T+270) ● 董秘 · Executives · 25 Apr 2025 · 派林生物 7,500 shares A股 SZSE:173000008868500580 Ideal exit: 20 Jan 2026 (T+270) ● 董事,高管 · Executives · 24 Feb 2025 · 派林生物 200 shares A股 SZSE:173000008717793300 Ideal exit: 21 Nov 2025 (T+270) ● 董事,高管 · Executives · 13 Feb 2025 · 派林生物 2,000 shares A股 SZSE:173000008552387420 Ideal exit: 10 Nov 2025 (T+270) ● 监事 · Executives · 14 Jan 2025 · 派林生物 1,500 shares A股 SZSE:173000008451201340 Ideal exit: 11 Oct 2025 (T+270) ● 监事 · Executives · 7 Jan 2025 · 派林生物 800 shares A股 SZSE:173000008409120800 Ideal exit: 4 Oct 2025 (T+270) ● 高管 · Executives · 6 Jan 2025 · 派林生物 10,000 shares A股 SZSE:173000008405393340 Ideal exit: 3 Oct 2025 (T+270) ● 董秘 · Executives · 6 Jan 2025 · 派林生物 2,000 shares A股 SZSE:173000008405393300 Ideal exit: 3 Oct 2025 (T+270) ● 高管 · Executives · 2 Jan 2025 · 派林生物 5,000 shares A股 SZSE:173000008396452540 Ideal exit: 29 Sept 2025 (T+270) ● 监事 · Executives · 2 Jan 2025 · 派林生物 2,000 shares A股 SZSE:173000008396452580 Ideal exit: 29 Sept 2025 (T+270) ● 高管 · Executives · 14 Nov 2024 · 尤夫股份 5,700 shares A股 SZSE:173000008264542800 Ideal exit: 11 Aug 2025 (T+270) ● 董事 · Executives · 30 Sept 2024 · 尤夫股份 4,000 shares A股 SZSE:173000008138114020 Ideal exit: 27 Jun 2025 (T+270) ● 董事 · Executives · 25 Jul 2024 · 尤夫股份 8,000 shares A股 SZSE:173000007882566600 Ideal exit: 21 Apr 2025 (T+270) ● 董事 · Executives · 26 Jun 2023 · 派林生物 3,500,000 shares A股 SZSE:173000006682573300 25 of 46 declarations
Load more (21 remaining) About 尹晨阳 Yin Chenyang is a Board Member at Fuan Co., Ltd. He plays a key role in the governance of the company, contributing to strategic decision-making and operational oversight. His experience in the sector is valuable for innovation.